MMSI (Medical supplies) Stock Valuation & Fair Value Weak on forward returns
MMSI (Medical supplies) trades at a current P/E of 22.2, about 11% below its historical normal valuation, with a forward growth estimate of 8.0% and a PEG of 2.78. Analysts' one-year estimates have been hit 45% of the time. Priced at its historical normal P/E of 25.0 on the same blended earnings, the 2026-10-23 close of $93.30 corresponds to about $105 a share. This is a valuation reference, not a price target.
How to read these numbers: the PEG ratio and current P/E versus normal P/E.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is MMSI overvalued?
At a current P/E of 22.2 versus its historical normal P/E of 25.0, MMSI trades about 11% below its typical valuation, with a PEG of 2.78 on 8.0% forward growth. tickerseer currently rates it weak on forward returns.
What is MMSI's fair value and PEG?
MMSI trades at a current P/E of 22.2 against a historical normal P/E of 25.0, a PEG of 2.78, and a forward growth estimate of 8.0%. Priced at its historical normal P/E of 25.0 on the same blended earnings, the 2026-10-23 close of $93.30 corresponds to about $105 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of MMSI changed?
tickerseer's rating has been weak on forward returns since 2026-10-24.
Industry: Medical supplies. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.